[1] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016,66:115-132. [2] European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol, 2018,69:182-236. [3] Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology, 2018,67:358-380. [4] 中华人民共和国卫生和计划生育委员会医政医管局. 原发性肝癌诊疗规范(2017年版). 中华肝脏病杂志, 2017,25:886-895. [5] Chen QW, Cheng CS, Chen H, et al. Effectiveness and complications of ultrasound guided fine needle aspiration for primary liver cancer in a Chinese population with serum alpha-fetoprotein levels ≤200 ng/ml--a study based on 4,312 patients. PLoS One, 2014,9:e101536. [6] Liebman HA, Furie BC, Tong MJ, et al. Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med, 1984,310:1427-1431. [7] 杨秉辉, 夏景林, 黄力文, 等. 我国肝癌“临床相”30年的变迁—原发性肝癌3250例的对比研究. 中华医学杂志, 2003,83:49-53. [8] Zhang XP, Wang K, Cheng SQ. Surveillance for early-stage hepatocellular carcinoma by ultrasound plus alpha-fetoprotein measurement: more details, more significance. Gastroenter-ology, 2018,155:1274-1275. [9] Luo P, Yin P, Hua R, et al. A Large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma. Hepatology, 2017. [10] Mazzaferro V, Droz DBM, Bhoori S. Alpha-Fetoprotein (AFP) in liver transplantation for HCC: The lower, the better. Hepatology, 2018. [11] 田州, 张建淮. 甲胎蛋白诊断和筛查原发性肝癌的阈值分析. 临床肝胆病杂志, 2018,34:2352-2355. [12] 丁国华, 顾猛. 肝癌实验室诊断指标的选择及最佳阈值探讨. 检验医学与临床, 2009,6:1515-1516. [13] 李冰, 郭珊, 曹献芹. 异常凝血酶原和甲胎蛋白在原发性肝癌诊断和疗效监测中的应用. 中国实用医刊, 2018,45:32-35. [14] Ette A I, Ndububa DA, Adekanle O, et al. Diagnostic utility of alpha-fetoprotein and des-gamma-carboxyprothrombin in nigeri-ans with hepatocellular carcinoma. Niger J Clin Pract, 2017,20:1267-1272. [15] Caviglia GP, Abate ML, Petrini E, et al. Highly sensitive alpha-fetoprotein, Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxyprothrombin for hepa-tocellular carcinoma detection. Hepatol Res, 2016,46:E130-E135. |